About four years after launch, Orna Therapeutics Inc. signed its second major deal, this time validating the lipid nanoparticle delivery technology it acquired through its Renagade Therapeutics Inc.
The initiative began with 265 high schools piloting Illustrative Math for algebra, but many teachers hated the tightly scripted lesson plans, rigid schedule, and requirement that students work in ...
Operating and Share Price Performance A cursory review of the segments suggests Ford’s troubles lie in its EV unit and (with a longer-term view) its in-house financing arm, which has seen its ...
Two Saudi Arabian agencies signed on with Vertex Pharmaceuticals to help boost the country’s gene therapy production capabilities during the first CPhI (Convention on Pharmaceutical Ingredients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback